One-Year Cardiovascular Outcomes in Patients With Peripartum Cardiomyopathy

Dayoub, Elias J.; Datwani, Hema; Lewey, Jennifer; Groeneveld, Peter W.

doi:10.1016/j.cardfail.2018.08.005

Cited by 10 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prognosis is related to initial LVEF, LV thrombosis, RV involvement, preeclampsia, geographic region, and race. 7,43–48 LV recovery and survival is generally favorable in developed countries 11,25,49 ; a 100-patient US registry showed 93% transplant/LVAD-free 1-year survival. 46…”

Section: Special Populationsmentioning

confidence: 99%

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

et al. 2022

View full text Add to dashboard Cite

Aim: The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.” The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. Methods: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021. Structure: Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients’ interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.

show abstract

Section: Special Populationsmentioning

confidence: 99%

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Forty‐seven studies, comprising 4875 patients across 60 countries, were considered eligible and were included in the systematic review ( Table 1 ). 1,15–65 A list of excluded studies, with reasons for exclusion, is provided in online supplementary Table .…”

Section: Resultsmentioning

confidence: 99%

A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta‐analysis

Hoevelmann

Engel

Muller

et al. 2022

European J of Heart Fail

View full text Add to dashboard Cite

Peripartum cardiomyopathy (PPCM) remains a major contributor to maternal morbidity and mortality worldwide. The disease is associated with various complications occurring mainly early during its course. Reported adverse outcomes include decompensated heart failure, thromboembolic complications, arrhythmias and death. We sought to systematically and comprehensively review published literature on the management and outcome of women with PPCM across different geographical regions and to identify possible predictors of adverse outcomes.

show abstract

“…Peripartum cardiomyopathy is an uncommon form of cardiomyopathy that develops during the later stages of pregnancy or shortly after giving birth [ 44 ]. In a matched retrospective cohort, AF was one of the most common incident CVD among women with peripartum cardiomyopathy one year after delivery [ 45 ]. Moreover, previous systematic reviews have reported that the prevalence of pregnancy-related complications, such as HDP was 22% (95% CI; 16%–28%) [ 46 ] and the prevalence of AF was 5% (1%–11%) [ 47 ] among women with peripartum cardiomyopathy.…”

Section: Discussionmentioning

confidence: 99%

Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review

Bahhawi

Aqeeli

Harrison

et al. 2023

JCM

View full text Add to dashboard Cite

Pregnancy-related complications are associated with a higher risk of various incident cardiovascular diseases, but their specific potential relationship with incident atrial fibrillation (AF) is less clear. This systematic review summarises the available evidence from observational studies which have examined associations between pregnancy-related complications and the risk of AF. MEDLINE and EMBASE (Ovid) were searched for studies between 1990 to 10 February 2022. Pregnancy-related complications examined included hypertensive disorders of pregnancy (HDP), gestational diabetes, placental abruption, preterm birth, small-for-gestational-age and stillbirth. Study selection, data extraction and quality assessment were completed independently by two reviewers. Narrative synthesis was used to evaluate the results of the included studies. Nine observational studies were included, with eight eligible for narrative synthesis. Sample sizes ranged from 1839 to 2,359,386. Median follow-up ranged from 2 to 36 years. Six studies reported that pregnancy-related complications were associated with a significantly increased risk of incident AF. Hazard ratios (HRs) (95% confidence intervals) for the four studies that evaluated HDP ranged from 1.1 (0.8–1.6) to 1.9 (1.4–2.7). For the four studies that evaluated pre-eclampsia, HRs ranged from 1.2 (0.9–1.6) to 1.9 (1.7–2.2). Current evidence from observational studies suggests pregnancy-related complications are associated with a significantly higher risk of incident AF. However, only a small number of studies examining each pregnancy-related complication were identified, and considerable statistical heterogeneity was observed. Further large-scale prospective studies are required to confirm the association between pregnancy-related complications and incident AF.

show abstract

One-Year Cardiovascular Outcomes in Patients With Peripartum Cardiomyopathy

Cited by 10 publications

References 13 publications

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta‐analysis

Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review

Contact Info

Product

Resources

About